E-LIB Suche - Ergebnisse für: Agema, Bram C.

1

Early Identification of Patients at Risk of Cabazitaxel-ind..:

Agema, Bram C. ; Buck, Stefan A.J. ; Viskil, Mano...
European Urology Oncology. 7 (2024) 4 - p. 786-793 , 2024

2

Toward model-informed precision dosing for tamoxifen: A pop..:

Agema, Bram C. ; Buijs, Sanne M. ; Sassen, Sebastiaan D.T....
Biomedicine & Pharmacotherapy. 160 (2023) - p. 114369 , 2023

Link: https://doi.org/10.1016/..

3

Improving the tolerability of osimertinib by identifying it..:

Agema, Bram C. ; Veerman, G. D. Marijn ; Steendam, Christi M. J....
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211032 , 2022

Link: https://doi.org/10.1177/..

4

Population Pharmacokinetics of Oxycodone and Metabolites in..:

Agema, Bram C. ; Oosten, Astrid W. ; Sassen, Sebastiaan D.T....
Cancers. 13 (2021) 11 - p. 2768 , 2021

Link: https://doi.org/10.3390/..

5

Influence of Genetic Variation in COMT on Cisplatin-Induced..:

Agema, Bram C. ; Koolen, Stijn L.W. ; de With, Mirjam...
Genes. 11 (2020) 4 - p. 358 , 2020

Link: https://doi.org/10.3390/..

6

The influence of single-nucleotide polymorphisms on overall..:

Belderbos, Bodine P. S. ; de With, Mirjam ; Singh, Rajbir K....
Cancer Chemotherapy and Pharmacology. 85 (2020) 3 - p. 547-553 , 2020

Link: https://doi.org/10.1007/..

7

Toward model-informed precision dosing for tamoxifen:A popu..:

Agema, Bram C ; Buijs, Sanne M ; Sassen, Sebastiaan D T...
https://pure.eur.nl/en/publications/9012b2b0-9bf9-413a-8686-34126b61f7e6. , 2023

Link: https://pure.eur.nl/en/p..

8

Early Identification of Patients at Risk of Cabazitaxel-ind..:

Agema, Bram C ; Buck, Stefan A J ; Viskil, Mano...
https://pure.eur.nl/en/publications/e4446acf-36ff-4e38-bdb0-d8e5232a94df. , 2023

Link: https://pure.eur.nl/en/p..

9

Early Identification of Patients at Risk of Cabazitaxel-ind..:

Agema, Bram C ; Buck, Stefan A J ; Viskil, Mano...
https://pure.eur.nl/en/publications/e4446acf-36ff-4e38-bdb0-d8e5232a94df. , 2023

Link: https://pure.eur.nl/en/p..

10

Toward model-informed precision dosing for tamoxifen:A popu..:

Agema, Bram C ; Buijs, Sanne M ; Sassen, Sebastiaan D T...
https://pure.eur.nl/en/publications/9012b2b0-9bf9-413a-8686-34126b61f7e6. , 2023

Link: https://pure.eur.nl/en/p..

11

Improving the tolerability of osimertinib by identifying it..:

Agema, Bram C ; Veerman, G. D.Marijn ; Steendam, Christi M.J...
https://pure.eur.nl/en/publications/95a2f6ee-d65e-45ca-bab2-7afbafac2b74. , 2022

Link: https://pure.eur.nl/en/p..

12

Improving the tolerability of osimertinib by identifying it..:

Agema, Bram C ; Veerman, G. D.Marijn ; Steendam, Christi M.J...
https://pure.eur.nl/en/publications/95a2f6ee-d65e-45ca-bab2-7afbafac2b74. , 2022

Link: https://pure.eur.nl/en/p..

13

Population pharmacokinetics of oxycodone and metabolites in..:

Agema, Bram C ; Oosten, Astrid W ; Sassen, Sebastiaan D.T...
https://pure.eur.nl/en/publications/12349215-d3a0-48da-a976-df822eb17277. , 2021

Link: https://pure.eur.nl/en/p..

14

Population pharmacokinetics of oxycodone and metabolites in..:

Agema, Bram C ; Oosten, Astrid W ; Sassen, Sebastiaan D.T...
Agema , B C , Oosten , A W , Sassen , S D T , Rietdijk , W J R , van der Rijt , C C D , Koch , B C P , Mathijssen , R H J & Koolen , S L W 2021 , ' Population pharmacokinetics of oxycodone and metabolites in patients with cancer‐related pain ' , Cancers , vol. 13 , no. 11 , 2768 . https://doi.org/10.3390/cancers13112768. , 2021

Link: https://pure.eur.nl/en/p..

15

Influence of genetic variation in COMT on cisplatin-induced..:

Agema, Bram C ; Koolen, Stijn L.W ; de With, Mirjam...
https://pure.eur.nl/en/publications/e48822be-aa8b-4c17-987d-6ea96c74088d. , 2020

Link: https://pure.eur.nl/en/p..